NVCT   $8.08  -1.70% Market Open

Nuvectis Pharma, Inc.

EMA (20): 2026-02-24 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (50): 2025-12-03 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

EMA (100): 2025-12-04 the price crossed up the moving average line and demonstrates an upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: main and signal line crossing.

Stochastic: The stochastic indicator is in the upper part of the neutral territory and it falls. These factors indicate that the downside trend is confirmed. Last signal: exit from the overbought zone.

Trend Type turning up
Power slow
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 1.84%
EMA (20) date of signal Feb. 24, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 38.87%
EMA (50) date of signal Dec. 3, 2025, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 31.36%
EMA (100) date of signal Dec. 4, 2025, 3 a.m.
RSI Signals bullish recovery
RSI (14) Yield 0.0
RSI (14) date of signal March 4, 2026, 3 a.m.
MACD Signals bullish weakening
MACD Yield 1.72%
MACD date of signal March 3, 2026, 3 a.m.
Stochastic Signals bearish reversal
Stochastic Yield 1.72%
Stochastic date of signal March 3, 2026, 3 a.m.
Updated March 4, 2026, 8:43 p.m.